Question 1

Does Pictet Asset Management Holding own IBRX stock?

Accepted Answer

Yes. As of its Q3 2026 13F, Pictet Asset Management Holding holds 832,486 shares of IBRX (ImmunityBio), worth $7.4M.

Question 2

How many shares of IBRX does Pictet Asset Management Holding own?

Accepted Answer

As of its Q3 2026 13F, Pictet Asset Management Holding holds 832,486 shares of IBRX (ImmunityBio).

Question 3

What is Pictet Asset Management Holding's IBRX position worth?

Accepted Answer

As of its Q3 2026 13F, Pictet Asset Management Holding's IBRX position is worth $7.4M.

Question 4

Is Pictet Asset Management Holding buying or selling IBRX?

Accepted Answer

In Q3 2026, Pictet Asset Management Holding reduced its IBRX position by 15,173 shares (-1.8%).

Question 5

When did Pictet Asset Management Holding first buy IBRX?

Accepted Answer

Pictet Asset Management Holding already held IBRX in its Q3 2023 13F, the earliest on record, and has listed it in 13 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Decreased	832,486	-1.8%	$7.4M	0.0%	$9.44	0
2026-Q2	Increased	847,659	+2.1%	$7.4M	0.0%	$8.76	28
2026-Q1	Increased	830,137	+2365.7%	$5.6M	0.0%	$7.67	44
2025-Q4	Unchanged	33,667	0.0%	$66,661	0.0%	$1.98	0
2025-Q3	Unchanged	33,667	0.0%	$82,821	0.0%	$2.46	0
2025-Q2	Increased	33,667	+56.2%	$88,881	0.0%	$2.64	31
2025-Q1	Unchanged	21,556	0.0%	$64,884	0.0%	$3.01	0
2024-Q4	Unchanged	21,556	0.0%	$55,183	0.0%	$2.56	0
2024-Q3	Unchanged	21,556	0.0%	$80,188	0.0%	$3.72	0